1. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience 
Corey J. Hobbs, MD, Stephen J. Ko, MD, Nitesh N. Paryani, MD, Joseph M. Accurso, MD, Kenneth R. Olivier, MD, Yolanda I. Garces, MD, Sean S. Park, MD, MS, PhD, Christopher L. Hallemeier, MD, Steven E. Schild, MD, Sujay A. Vora, MD, Jonathan B. Ashman, MD, PhD, William G. Rule, MD, Johnny R. Bowers, BS, Michael G. Heckman, MS, Nancy N. Diehl, MBA, Robert C. Miller, MD 
Mayo Clinic Proceedings: Innovations, Quality & Outcomes  
Volume 2, Issue 1, Pages (March 2018)
DOI: /j.mayocpiqo
Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Figure 1
Kaplan-Meier curves showing cumulative incidence of recurrence according to maximum standardized uptake values (SUVmax). Patients were divided into 3 groups of SUVmax on the basis of sample tertiles: low SUVmax, <4.3 (n=91), moderate SUVmax, (n=98), and high SUVmax, >8.7 (n=93).
Mayo Clinic Proceedings: Innovations, Quality & Outcomes  2018 2, 40-48DOI: ( /j.mayocpiqo )
Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions

3. Figure 2
Kaplan-Meier curves showing cumulative incidence of local recurrence according to biologically effective dose (n=271). Patients were divided on the basis of Gy fractions: 48 Gy in 4 fractions (n=148), 50 Gy in 5 fractions (n=56), or 54 Gy in 3 fractions (n=67).
Mayo Clinic Proceedings: Innovations, Quality & Outcomes  2018 2, 40-48DOI: ( /j.mayocpiqo )
Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions